Viread (A-S Medication Solutions)
Welcome to the PulseAid listing for the Viread drug offered from A-S Medication Solutions. This Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | A-S Medication Solutions |
| NON-PROPRIETARY NAME: | TENOFOVIR DISOPROXIL FUMARATE |
| SUBSTANCE NAME: | TENOFOVIR DISOPROXIL FUMARATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2001-10-26 |
| END MARKETING DATE: | 0000-00-00 |
Viread HUMAN PRESCRIPTION DRUG Details:
| Item Description | Viread from A-S Medication Solutions |
| LABELER NAME: | A-S Medication Solutions |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 300(mg/1) |
| START MARKETING DATE: | 2001-10-26 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 50090-0754_ea07bdcf-3567-4ba9-9d30-e73b51394b8b |
| PRODUCT NDC: | 50090-0754 |
| APPLICATION NUMBER: | NDA021356 |
Other TENOFOVIR DISOPROXIL FUMARATE Pharmaceutical Manufacturers / Labelers:
